Explainable Predictions of Renal Cell Carcinoma with Interpretable Tree Ensembles from Contrast-enhanced CT Images

被引:1
|
作者
Han, Fuchang [1 ]
Liao, Shenghui [1 ]
Wu, Renzhong [1 ]
Liu, Shu [1 ]
Zhao, Yuqian [1 ]
Xie, Yu [1 ]
机构
[1] Cent South Univ, Sch Comp Sci & Engn, Changsha, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
renal cell carcinoma; explainable predictions; Shapley additive explanations; decision curve analysis; TEXTURE ANALYSIS; CALIBRATION; IMPACT; MODELS;
D O I
10.1109/IJCNN52387.2021.9534147
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Diagnosis of renal cell carcinoma (RCC) is critical in automated clinical decision-support system. Existing state-of-the-art methods focus on designing complex machine learning models for high identification accuracy; especially, deep neural networks improve the prediction accuracy. Such designs ignore the explainability of models, and their "black box" nature is a barrier to model trust. In addition, little attention has been paid to evaluating clinical utility. To explain model predictions and evaluate risks and benefits, this paper introduces the explainable machine learning predictions that incorporate the balancing of risks and benefits of treatment to RCC prediction models. The proposed explainable network is based on tree ensembles with four improvements: (1) A multiscale feature extraction module, obtaining comprehensive radiomic features; (2) An attribute optimization module based on Chi-square test, guiding the network to focus on useful information at variables; (3) Appending a SHapley Additive exPlanations (SHAP) module to the framework to automatically and efficiently interpret the prediction of the models; And (4) a decision curve analysis (DCA) module is performed for the clinical utility evaluation. By integrating the above improvements in series, the models' performances are gradually enhanced. By the comparison of different tree ensembles-based algorithms, our study finds the random forest (RF) and extra trees (ET) classifier can be valuable diagnosis tools for explainable RCC predictions. To demonstrate the generalizability, our tree ensembles-based models achieve higher accuracies than the state-of-the-art pretrained deep models with fine-tuned parameters.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] The independent indicators for differentiating renal cell carcinoma from renal angiomyolipoma by contrast-enhanced ultrasound
    Cao, Hongli
    Fang, Liang
    Chen, Lin
    Zhan, Jia
    Diao, Xuehong
    Liu, Yingchun
    Lu, Chen
    Zhang, Zhengwang
    Chen, Yue
    BMC MEDICAL IMAGING, 2020, 20 (01)
  • [22] Low Enhancement on Multiphase Contrast-Enhanced CT Images: An Independent Predictor of the Presence of High Tumor Grade of Clear Cell Renal Cell Carcinoma
    Zhu, Ye-Hua
    Wang, Xun
    Zhang, Jin
    Chen, Yong-Hui
    Kong, Wen
    Huang, Yi-Ran
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 203 (03) : W295 - W300
  • [23] Comparison of Contrast-Enhanced Multiphase Renal Protocol CT Versus MRI for Diagnosis of Papillary Renal Cell Carcinoma
    Dilauro, Marc
    Quon, Matthew
    McInnes, Matthew D. F.
    Vakili, Maryam
    Chung, Andrew
    Flood, Trevor A.
    Schieda, Nicola
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2016, 206 (02) : 319 - 325
  • [24] Quantitative Measurement on Contrast-Enhanced CT Distinguishes Small Clear Cell Renal Cell Carcinoma From Benign Renal Tumors: A Multicenter Study
    Luo, Shiwei
    Lin, Wanxian
    Wu, Jialiang
    Zhang, Wanli
    Kui, Xiaoyan
    Lai, Shengsheng
    Wei, Ruili
    Pang, Xinrui
    Wang, Ye
    He, Chutong
    Liu, Jun
    Yang, Ruimeng
    ACADEMIC RADIOLOGY, 2024, 31 (04) : 1460 - 1471
  • [25] The value of quantitative CT texture analysis in differentiation of angiomyolipoma without visible fat from clear cell renal cell carcinoma on four-phase contrast-enhanced CT images
    You, M-W
    Kim, N.
    Choi, H. J.
    CLINICAL RADIOLOGY, 2019, 74 (07) : 547 - 554
  • [26] Contrast-Enhanced CT Renal Tumor Segmentation
    Xiao, Chuda
    Hassan, Haseeb
    Huang, Bingding
    KIDNEY AND KIDNEY TUMOR SEGMENTATION, KITS 2021, 2022, 13168 : 116 - 122
  • [27] Re: Evaluation of Adrenal Metastases from Renal Cell Carcinoma and Hepatocellular Carcinoma: Use of Delayed Contrast-Enhanced CT Editorial Comment
    Siegel, Cary
    JOURNAL OF UROLOGY, 2013, 190 (06): : 2018 - 2019
  • [28] Metastatic Renal Carcinoma: Evaluation of Antiangiogenic Therapy with Dynamic Contrast-enhanced CT
    Fournier, Laure S.
    Oudard, Stephane
    Thiam, Rokhaya
    Trinquart, Ludovic
    Banu, Eugeniu
    Medioni, Jacques
    Balvay, Daniel
    Chatellier, Gilles
    Frija, Guy
    Cuenod, Charles A.
    RADIOLOGY, 2010, 256 (02) : 511 - 518
  • [29] Renal cell carcinoma subtype differentiation using single-phase corticomedullary contrast-enhanced CT
    Gomes, Filipe Veloso
    Matos, Antonio P.
    Palas, Joao
    Mascarenhas, Vasco
    Heredia, Vasco
    Duarte, Sergio
    Ramalho, Miguel
    CLINICAL IMAGING, 2015, 39 (02) : 273 - 277
  • [30] Evaluation of Response to Multikinase Inhibitor in Metastatic Renal Cell Carcinoma by FDG PET/Contrast-Enhanced CT
    Minamimoto, Ryogo
    Nakaigawa, Noboru
    Tateishi, Ukihide
    Suzuki, Akiko
    Shizukuishi, Kazuya
    Kishida, Takeshi
    Miura, Takeshi
    Makiyama, Kazuhide
    Yao, Masahiro
    Kubota, Yoshinobu
    Inoue, Tomio
    CLINICAL NUCLEAR MEDICINE, 2010, 35 (12) : 918 - 923